Michael H Pillinger

21PUBLICATIONS
33CO-AUTHORS
PharmacogenomicsGeomorphology and earth surface processesNaturopathyCardiology (incl. cardiovascular diseases)Nutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jun 26, 2026
Efficacy and Safety of Nanoencapsulated Sirolimus Plus Pegadricase: Results From the Randomized, Placebo-Controlled Phase 3 Trials.

|Oct 20, 2025
Climate Change, Environmental Risk Factors, and Gout.

Mary L Guan, Tamiko R Katsumoto, Michael Toprover

|Aug 07, 2025
Improvements in Health-Related Quality of Life With Treat-to-Target Urate-Lowering Therapy in Gout: A Post Hoc Analysis of a Randomized Multicenter Trial.

Austin Barry, Bryant R England, Harlan Sayles

|Jul 14, 2025
Some More Equal Than Others: The Divergence of Cardiac Risk in the Use of Nonsteroidal Anti-Inflammatory Drugs Versus Colchicine for Treating and Preventing Gout.

Michael H Pillinger, Michael Toprover

|Jul 05, 2025
Gout, Hyperuricemia, and the Intestinal Microbiome.

Nicholas Renton, Michael H Pillinger, Michael Toprover

|Jul 01, 2025
Endothelial Cell and Neutrophil Activation in Untreated Intercritical Patients With Gout.

Michael Toprover, Binita Shah, Kamelia Drenkova

Pageof 4

Frequent Collaborators

7 joint publications

Tuhina Neogi

6 joint publications

Michael Toprover

5 joint publications

Ted R Mikuls

3 joint publications

John Fitzgerald